Team:UCL London/Future Vision
From 2010.igem.org
Line 2: | Line 2: | ||
=FUTURE VISION= | =FUTURE VISION= | ||
+ | |||
+ | [[Image:UCL-brainsotrm.JPG||300px|right]] | ||
At this stage, our main aim is to one of proof of principle, to show that our circuit does in fact react in the way it does to hypoxia. Pending this achievable target, we have high hopes of our Principle being implemented in a potentially infinite number of ways. We have split them into the following main categories just to give you an idea. | At this stage, our main aim is to one of proof of principle, to show that our circuit does in fact react in the way it does to hypoxia. Pending this achievable target, we have high hopes of our Principle being implemented in a potentially infinite number of ways. We have split them into the following main categories just to give you an idea. |
Revision as of 00:17, 8 September 2010
FUTURE VISION
At this stage, our main aim is to one of proof of principle, to show that our circuit does in fact react in the way it does to hypoxia. Pending this achievable target, we have high hopes of our Principle being implemented in a potentially infinite number of ways. We have split them into the following main categories just to give you an idea.
Health & Medicine
Imagine if the bacteria as we know it today could drive protein expression with the lack of oxygen. Synthetic biology through biochemical engineering can create the potential at which Escherichia coli cells- and we all know how harmful to humans can specific strains be- used in a twisted yet beautifully way as an expression system for the production of biopharmaceuticals. The project is based on the engineering modification of the cells and the construction of a self-induced biological circuit that allows an automated protein expression
Manufacturing
We all remember the Swine flu pandemic that outbreak? A year ago. The production of such a great amount of pharmaceuticals in such a short time to cover the needs of x people, was only based on a well planned engineering scale-up equations and an established protocol. Therefore, in order to create a product and with regards to our project, a pharmaceutical drug, there is the need to establish the conditions that will enable the effective development of the process and the efficient and most economically viable product. By decreasing the cost of the project, it only means that it is delivered to the patient at a lower cost. By producing more naturally occurring drugs, avoiding as much as possible chemicals that can cause damage to the cells or side-effects of the tablet, meaning that a safer product has been manufactured and is ready for consumption.